7/28/2019 Oncology - Esophageal Ca v2

1/24

, , .

7/28/2019 Oncology - Esophageal Ca v2

2/24

14 , 3% .

45-62 . .

5 : 3 .

2000 8,0 1,5 100 . .

7/28/2019 Oncology - Esophageal Ca v2

3/24

(), , *),() ,,

. , CARCINOMA IN CITU...

, .

7/28/2019 Oncology - Esophageal Ca v2

4/24

. -

,

, ,.

50%.

7/28/2019 Oncology - Esophageal Ca v2

5/24

10%

..65%

25%

7/28/2019 Oncology - Esophageal Ca v2

6/24

. . (, ) /95%/.

...1%, - ,... 1%. .............. 1% (, ,

GIST*). 1-3%*)-GIST- - (Mazur M., Clark H./1983/). , , , , D-117 ( -kit). , .

7/28/2019 Oncology - Esophageal Ca v2

7/24

. . ( ) :

1. ()

2. ()

3. -------------------------------

0.

7/28/2019 Oncology - Esophageal Ca v2

8/24

0

T is (carcinoma in citu) -

N+

1 11%

2 80%

3 90%

4 >90%

0

T is (carcinoma in citu) -

N+

1 11%

2 80%

3 90%

4 >90%

. .

7/28/2019 Oncology - Esophageal Ca v2

9/24

. . N TNM UICC VI (2002):

N

N0 N1

M

M1

M1

M1

M1

M1

M1

7/28/2019 Oncology - Esophageal Ca v2

10/24

. .

- ,

- ,

.

7/28/2019 Oncology - Esophageal Ca v2

11/24

. .

: , , , , ,, ,

: , .

- .

7/28/2019 Oncology - Esophageal Ca v2

12/24

. .

4 :

1 - ;

2 - ;

3 - ; 4 ( )-

.

7/28/2019 Oncology - Esophageal Ca v2

13/24

-

-

-

. .

7/28/2019 Oncology - Esophageal Ca v2

14/24

. .

: ( 4 ). .

, -(, ) .

, , . . . .

7/28/2019 Oncology - Esophageal Ca v2

15/24

. .

-.

:o (

)

o o .

:

7/28/2019 Oncology - Esophageal Ca v2

16/24

. .

7/28/2019 Oncology - Esophageal Ca v2

17/24

. .

. ( ).

+ + (0,1% ) - . , , . .

(/) . (/) . --. .

.

7/28/2019 Oncology - Esophageal Ca v2

18/24

. .

.

90-60%. 25-45%. 5- 20-30%. . .- .

. FLE; 2 1 .:25 /2 (1-3), 20 /2 (1-3),80 /2 (1-3), 80 /2( 4

; ).

7/28/2019 Oncology - Esophageal Ca v2

19/24

. . .

- *)

:

6 :

,

+ (FLEP)

7/28/2019 Oncology - Esophageal Ca v2

20/24

. .1. (I. Lewis, 1946)- (

- (-)

-

2. (T.Oshawa - J.Harlock; 1933-41)- (, )

- ()

-

3. / / .

- () (.. , 1929)

7/28/2019 Oncology - Esophageal Ca v2

21/24

. .

, , .

- ( )

7/28/2019 Oncology - Esophageal Ca v2

22/24

3-4 , , ,,

: 1-3 ,

25-30% ,

,

. .

7/28/2019 Oncology - Esophageal Ca v2

23/24

(

).

.

,

.

. .

7/28/2019 Oncology - Esophageal Ca v2

24/24

.